newsfilter
← Latest News
GlobeNewswire·

Zogenix To Present New FINTEPLA® (fenfluramine) Data at AES 2021

EMERYVILLE, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ:ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that it will present new FINTEPLA® (fenfluramine) data from eight a